&Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
&Partners's BCAT Position: Q2 2026 in Review
&Partners increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 3% in Q2 2026, buying an estimated $22.3K and bringing the position to 49,364 shares worth $786K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.
&Partners first reported a position in BCAT in Q3 2024 and has held it in 8 quarters since. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- &Partners held 49,364 shares of BlackRock Capital Allocation Term Trust worth $786K as of Q2 2026.
- &Partners bought 1,450 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $22.3K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1563 holding.
- &Partners first reported a position in BlackRock Capital Allocation Term Trust in Q3 2024 and has held it in 8 quarters since.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.